| 000 | 01353 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512203753.0 | ||
| 264 | 0 | _c19801024 | |
| 008 | 198010s 0 0 eng d | ||
| 022 | _a0021-9738 | ||
| 024 | 7 |
_a10.1172/JCI109841 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan Epps, D E | |
| 245 | 0 | 0 |
_aEnhancement of neutrophils function as a result of prior exposure to chemotactic factor. _h[electronic resource] |
| 260 |
_bThe Journal of clinical investigation _cAug 1980 |
||
| 300 |
_a167-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlood Bactericidal Activity |
| 650 | 0 | 4 |
_aChemotactic Factors _xpharmacology |
| 650 | 0 | 4 | _aChemotaxis, Leukocyte |
| 650 | 0 | 4 |
_aExudates and Transudates _xphysiology |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLuminescent Measurements |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 | _aOpsonin Proteins |
| 650 | 0 | 4 |
_aReceptors, Complement _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Drug _xphysiology |
| 650 | 0 | 4 |
_aReceptors, Fc _xmetabolism |
| 650 | 0 | 4 |
_aSuperoxides _xmetabolism |
| 700 | 1 | _aGarcia, M L | |
| 773 | 0 |
_tThe Journal of clinical investigation _gvol. 66 _gno. 2 _gp. 167-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI109841 _zAvailable from publisher's website |
| 999 |
_c6249781 _d6249781 |
||